Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2013-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-012-2404-yPMID 23292119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes, metformin, and breast cancer in postmenopausal women.

  2012cited by this paper
• Mortality After Incident Cancer in People With and Without Type 2 Diabetes

  2012cited by this paper
• Carbon coated superparamagnetic iron oxide nanoparticles for sentinel lymph nodes mapping.

  2012cited by this paper
• Type 2 diabetes mellitus and prognosis in early stage breast cancer women

  2012cited by this paper
• Breast cancer manifested by hematologic disorders.

  2012cited by this paper
• Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.

  2012cited by this paper
• MortalityAfter Incident Cancer in People With andWithout Type 2 Diabetes Impact of metformin on survival

  2012cited by this paper
• Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer

  2012cited by this paper
• A balancing act for breast cancer? Everolimus for hormone receptor positive patients

  2012cited by this paper
• The impact of type 2 diabetes mellitus on cancer‐specific survival

  2012cited by this paper
• Metformin and breast cancer risk: a meta-analysis and critical literature review

  2012cited by this paper
• Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial

  2011cited by this paper
• Association between body-mass index and risk of death in more than 1 million Asians.

  2011cited by this paper
• Clinical features and molecular phenotypes of breast cancer in patients with type-2 diabetes mellitus.

  2011cited by this paper
• National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

  2011cited by this paper
• Linking diabetes and cancer: a consensus on complexity.

  2010cited by this paper
• The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth

  2010cited by this paper
• Type 2 diabetes mellitus and characteristics of breast cancer in China.

  2010cited by this paper
• [Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives].

  2010cited by this paper
• Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study.

  2010cited by this paper
• Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo

  2010cited by this paper
• New Users of Metformin Are at Low Risk of Incident Cancer

  2009cited by this paper
• Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.

  2009cited by this paper
• The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells

  2009cited by this paper
• Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

  2008cited by this paper
• Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients.

  2008cited by this paper
• Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

  2008cited by this paper
• The Impact of Transgenic IGF-IR Overexpression on Mammary Development and Tumorigenesis

  2008cited by this paper
• The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase

  2008cited by this paper
• Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

  2007cited by this paper
• Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.

  2007cited by this paper
• Insulin Signaling in Health and Disease

  2003cited by this paper
• Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis.

  2002cited by this paper
• The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle

  2000cited by this paper

• Relationship between Type 2 Diabetes and Five-Year Survival of Breast Cancer Patients: A Retrospective Cohort Study

  2025cites this paper
• LEP and FOXO1 genes, as a proposed tumor suppressor autophagic cell death related genes, can be targeted by antidiabetic therapy in nondiabetic breast cancer patients

  2025cites this paper
• Predictive factors for the response to neoadjuvant treatment in patients with stage II and III breast cancer.

  2025cites this paper
• Association of metformin use and cancer incidence: a systematic review and meta-analysis.

  2024cites this paper
• North American Clinical Practice Guidelines for the Medical Management of Hidradenitis Suppurativa in Special Patient Populations.

  2024cites this paper
• A randomized controlled study of neoadjuvant metformin with chemotherapy in nondiabetic breast cancer women: The METNEO study

  2024cites this paper
• Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells

  2023cites this paper
• Hypertension and hyperglycaemia are positively correlated with local invasion of early cervical cancer

  2023cites this paper
• Association between diabetes status and breast cancer in US adults: findings from the US National Health and Nutrition Examination Survey

  2023cites this paper
• Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications.

  2023cites this paper
• Impaired Glucose Metabolism, Anti-Diabetes Medications, and Risk of Thyroid Cancer

  2022cites this paper
• Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies

  2022cites this paper
• Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis

  2022cites this paper
• Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy

  2022cites this paper
• Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis

  2022cites this paper
• RETRACTED: Metformin and Breast Cancer: Where Are We Now?

  2022cites this paper
• Pathological Significance of GLUT-1 Expression in Breast Cancer Cells in Diabetic and Obese Patients: The French Guiana Study

  2022cites this paper
• Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC

  2021cites this paper
• Clinicopathological Data of Breast Cancer in Diabetic Patients

  2021influential citation
• Mechanisms of Action of Metformin

  2021cites this paper
• Effects of metformin on human bone-derived mesenchymal stromal cell—breast cancer cell line interactions

  2021cites this paper
• A molecular link between diabetes and breast cancer: Therapeutic potential of repurposing incretin-based therapies for breast cancer.

  2021cites this paper
• Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes

  2021cites this paper
• Glycosylated Hemoglobin A1c Is Associated with Anthropometric Measurements and Tumor Characteristics in Breast Cancer Patients

  2020cites this paper
• Metformin-induced TRAIL Upregulation Promotes Apoptosis in Triple Negative Breast Cancer and Non-small Cell Lung Cancer Cells

  2020cites this paper
• Mechanisms of metformin inhibiting cancer invasion and migration.

  2020cites this paper
• Relationship between diabetes mellitus and clinicopathological stages of breast cancer at diagnosis

  2020cites this paper
• Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study

  2020cites this paper
• Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status

  2020cites this paper
• Impact of preexisting type 2 diabetes mellitus and antidiabetic drugs on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breast cancer.

  2020cites this paper
• Preventive and (Neo)Adjuvant Therapeutic Effects of Metformin on Cancer

  2020cites this paper
• Metformin suppresses the proliferation and invasion through NF-kB and MMPs in MCF-7 cell line

  2019cites this paper
• Body mass index and diabetes are important prognostic signatures for bilateral breast cancer prognosis

  2019cites this paper
• Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries

  2019influential citation
• Diabetes mellitus and cancer incidence: the Atherosclerosis Risk in Communities (ARIC) cohort study

  2019cites this paper
• Metformin as an adjuvant in breast cancer treatment

  2019cites this paper
• Relationship between Diabetes and Diabetes Medications and Risk of Different Molecular Subtypes of Breast Cancer

  2019cites this paper
• Metformin : A Future Anticancerous Drug

  2019cites this paper
• [Survival impact of diabetes and paraneoplastic thrombocytosis in women with breast cancer].

  2019cites this paper
• The role of metformin and statins in ovarian and breast cancer in women with type 2 diabetes

  2019influential citation
• Role of Insulin on Breast Cancer Patients

  2019cites this paper
• A cukorbetegség és a daganatos thrombocytosis túlélésre gyakorolt hatásának vizsgálata emlőtumoros nőkben Survival impact of diabetes and paraneoplastic thrombocytosis in women with breast cancer

  2019cites this paper
• A cukorbetegség és a daganatos thrombocytosis túlélésre gyakorolt hatásának vizsgálata emlőtumoros nőkben Survival impact of diabetes and paraneoplastic thrombocytosis in women with breast cancer

  2019cites this paper
• Impact of type II Diabetes Mellitus on Outcomes of Breast Cancers among Egyptian Females.

  2018cites this paper
• Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment

  2018cites this paper
• Breast cancer extent and survival among diabetic women in a Finnish nationwide cohort study

  2018cites this paper
• Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy

  2018cites this paper
• A Hybrid Machine Learning Scheme to Analyze the Risk Factors of Breast Cancer Outcome in Patients with Diabetes Mellitus

  2018cites this paper
• The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors

  2018cites this paper
• Antiproliferative and antiangiogenic effects of metformin on multidrug-resistant MCF-7 cells

  2018cites this paper
• The Effect of Metformin on Absolute Telomere Length

  2018cites this paper
• Proteomic modulation in breast tumors after metformin exposure: results from a “window of opportunity” trial

  2017cites this paper
• Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension, and Risk of Inflammatory and Other Breast Cancer

  2017cites this paper
• High glucose and high insulin conditions promote MCF-7 cell proliferation and invasion by upregulating IRS1 and activating the Ras/Raf/ERK pathway

  2017cites this paper
• Zinc and its transporter ZIP6 are key mediators of breast cancer cell survival under high glucose conditions

  2017cites this paper
• Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study

  2017cites this paper
• Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?

  2017cites this paper
• Diabetes and Breast Cancer Subtypes

  2017cites this paper
• Synthetic Lethal Metabolic Targeting of Senescent Cells After Androgen Deprivation Therapy

  2017cites this paper
• The inhibitory effects of nano-encapsulated metformin on growth and hTERT expression in breast cancer cells

  2017cites this paper
• Potential Roles of GLUT12 for Glucose Sensing and Cellular Migration in MCF-7 Human Breast Cancer Cells Under High Glucose Conditions.

  2017cites this paper
• The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer

  2016cites this paper
• Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression.

  2016cites this paper
• A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers

  2016cites this paper
• Diabetes mellitus and prognosis in women with breast cancer

  2016cites this paper
• Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning.

  2016cites this paper
• Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro

  2016cites this paper
• The expression difference of insulin-like growth factor 1 receptor in breast cancers with or without diabetes.

  2015cites this paper
• Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes

  2015cites this paper
• Impact of Diabetes on the Prognosis of Breast Cancer: a Meta Analysis

  2015cites this paper
• Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence

  2015cites this paper
• A Framework for the Multilevel Integration of Molecular, Clinical, and Population Data in the Context of Breast Cancer: Challenges and Considerations of Socioecological Conditions and Pharmacogenomics

  2015cites this paper
• Metformin in cancer treatment and prevention.

  2015cites this paper
• Comorbidities and Their Management: Potential Impact on Breast Cancer Outcomes.

  2015cites this paper
• Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid Cancer

  2015cites this paper
• The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes

  2015cites this paper
• Metformin, an old drug, brings a new era to cancer therapy.

  2015cites this paper
• Recent Progress in Research of Nonalcoholic Fattyliver Disease*

  2015cites this paper
• Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?

  2015cites this paper
• Metformin Effects on Malignant Cells and Healthy PBMC; The Influence of Metformin on the Phenotype of Breast Cancer Cells

  2015cites this paper
• Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress

  2015cites this paper
• Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis

  2015cites this paper
• The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer

  2015influential citation
• Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study

  2015cites this paper
• Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis.

  2015cites this paper
• The association between diabetes and breast cancer stage at diagnosis: a population-based study

  2015cites this paper
• CuraEx - Clinical Expert System Using Big-Data for Precision Medicine

  2015cites this paper
• Diabetes, diabetes treatment and breast cancer prognosis

  2014cites this paper
• Treatment and outcomes in diabetic breast cancer patients

  2014influential citation
• Metformin exposure and disseminated disease in patients with colorectal cancer.

  2014cites this paper
• Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies

  2014influential citation
• Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People’s Republic of China

  2014cites this paper
• Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer

  2014cites this paper
• The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta‐analysis

  2014cites this paper
• DIABETIC STUDIES The Review of Metformin and Cancer

  2014cites this paper
• Metformin and survival in diabetic patients with breast cancer.

  2014cites this paper
• The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.

  2014cites this paper
• The effect of metformin on breast cancer outcomes in patients with type 2 diabetes

  2014cites this paper
• Metformin and cancer.

  2013cites this paper
• Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China

  2013influential citation